Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancy
Bingjie Wang, Qian Wang, Zeyin Liang, Yue Yin, Lihong Wang, Qingya Wang, Yuan Li, Jinping Ou, Hanyun Ren, Yujun Dong
Topics & Concepts
MedicineTocilizumabInternal medicineHematologyCytokine stormAdjuvantAdjuvant therapyMalignancyImmunologyGastroenterologyChemotherapyDiseaseInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)Sepsis Diagnosis and TreatmentInflammasome and immune disordersNeutropenia and Cancer Infections